These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 27176622

  • 21. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
    Stucker F, Ponte B, Tataw J, Martin PY, Wozniak H, Pugin J, Saudan P.
    Crit Care; 2015 Mar 18; 19(1):91. PubMed ID: 25881975
    [Abstract] [Full Text] [Related]

  • 22. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
    Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Strampelli E, Pierucci A.
    Crit Care; 2012 Jun 27; 16(3):R111. PubMed ID: 22738289
    [Abstract] [Full Text] [Related]

  • 23. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration.
    Fealy N, Baldwin I, Johnstone M, Egi M, Bellomo R.
    Int J Artif Organs; 2007 Apr 27; 30(4):301-7. PubMed ID: 17520566
    [Abstract] [Full Text] [Related]

  • 24. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P, Kijkriengkraikul N, Leelahavanichkul A, Srisawat N, Praditpornsilpa K, Eiam-Ong S.
    Ther Apher Dial; 2011 Dec 27; 15(6):556-64. PubMed ID: 22107692
    [Abstract] [Full Text] [Related]

  • 25. Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Jacobs R, Verbrugghe W, Dams K, Roelant E, Couttenye MM, Devroey D, Jorens P.
    Life (Basel); 2023 May 17; 13(5):. PubMed ID: 37240843
    [Abstract] [Full Text] [Related]

  • 26. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis.
    Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S, Chen X.
    Crit Care; 2019 Jan 24; 23(1):22. PubMed ID: 30678706
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
    Sık G, Demirbuga A, Annayev A, Citak A.
    Int J Artif Organs; 2020 Apr 24; 43(4):234-241. PubMed ID: 31856634
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Continuous renal replacement therapy with regional citrate anticoagulation: do we really know the details?
    Lanckohr C, Hahnenkamp K, Boschin M.
    Curr Opin Anaesthesiol; 2013 Aug 24; 26(4):428-37. PubMed ID: 23673990
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, Fu P.
    Am J Kidney Dis; 2014 Mar 24; 63(3):479-90. PubMed ID: 24125729
    [Abstract] [Full Text] [Related]

  • 34. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.
    Valle EO, Cabrera CPS, Albuquerque CCC, Silva GVD, Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Lins PRG, Rodrigues CE.
    Crit Care; 2021 Aug 19; 25(1):299. PubMed ID: 34412667
    [Abstract] [Full Text] [Related]

  • 35. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT).
    Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL.
    Nephrol Dial Transplant; 2005 Jul 19; 20(7):1416-21. PubMed ID: 15855212
    [Abstract] [Full Text] [Related]

  • 36. Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial.
    Ratanarat R, Phairatwet P, Khansompop S, Naorungroj T.
    Blood Purif; 2023 Jul 19; 52(5):455-463. PubMed ID: 36858026
    [Abstract] [Full Text] [Related]

  • 37. Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation.
    Margraf A, Liu C, Küllmar M, Meersch M, Rossaint J, Zarbock A.
    Cells; 2022 Jun 01; 11(11):. PubMed ID: 35681510
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial.
    Meersch M, Küllmar M, Wempe C, Kindgen-Milles D, Kluge S, Slowinski T, Marx G, Gerss J, Zarbock A, SepNet Critical Care Trials Group.
    BMJ Open; 2019 Jan 21; 9(1):e024411. PubMed ID: 30670518
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.